Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Rule 2.10 Announcement

1 Mar 2010 07:00

RNS Number : 8092H
Consort Medical PLC
28 February 2010
 



Consort Medical PLC

 

Rule 2.10 Announcement

 

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers (the "Code"), Consort Medical plc ("Consort") confirms that it has 28,943,922 ordinary shares of 10 pence each in issue. The International Securities Identification Number for the ordinary shares is GB0000946276.

 

Evercore Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Consort and for no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than Consort for providing the protections afforded to clients of Evercore Partners Limited or for providing advice in relation to the matters set out in this announcement.

 

Dealing Disclosure Requirements

 

Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, 'interested' (directly or indirectly) in 1 per cent. or more of any class of 'relevant securities' of Consort or of Advanced Medical Solutions Group plc ("AMS"), all 'dealings' in any 'relevant securities' of Consort or of AMS (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by not later than 3.30 p.m. (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which any offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the 'offer period' otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Consort or AMS, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Consort or of AMS by Consort or AMS or by any of their respective 'associates', must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

 

A disclosure table, giving details of companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk.

 

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RTTUWSKRRNAUUAR
Date   Source Headline
1st Nov 20179:35 amRNSDirector/PDMR Shareholding
1st Nov 20179:04 amRNSTotal Voting Rights
16th Oct 20179:42 amRNSBlock listing Interim Review
11th Oct 20172:10 pmRNSDirector/PDMR Shareholding
11th Oct 201711:38 amRNSHolding(s) in Company
2nd Oct 201710:03 amRNSTotal Voting Rights
11th Sep 20175:15 pmRNSDirector/PDMR Shareholding
7th Sep 20171:56 pmRNSDirector/PDMR Shareholding
6th Sep 20174:35 pmRNSResult of AGM
1st Sep 20172:47 pmRNSDirector Declaration
10th Aug 20178:38 amRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
28th Jul 20173:48 pmRNSPosting of Annual Financial Report and AGM Notice
26th Jul 20179:22 amRNSDirector/PDMR Shareholding
20th Jul 20178:07 amRNSAdditional Listing
11th Jul 20178:53 amRNSDirector/PDMR Shareholding
21st Jun 201712:10 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
15th Jun 20177:00 amRNSFull year results
5th Jun 201710:09 amRNSDirector Declaration
8th May 20177:00 amRNSNotice of Results
2nd May 201711:10 amRNSTotal Voting Rights
27th Apr 201711:51 amRNSResult of General Meeting
18th Apr 20179:36 amRNSBlock listing Interim Review
3rd Apr 20179:49 amRNSNotice of GM
1st Mar 20179:22 amRNSTotal Voting Rights
30th Jan 201712:44 pmRNSHolding(s) in Company
26th Jan 20172:59 pmRNSHolding(s) in Company
23rd Jan 20177:00 amRNSParticipation in equity raise for Atlas Genetics
3rd Jan 20177:00 amRNSVoke® (DEV200) update
15th Dec 20169:45 amRNSHolding(s) in Company
14th Dec 201610:35 amRNSHolding(s) in Company
14th Dec 20167:00 amRNSDirectorate Change
9th Dec 20163:18 pmRNSDirector/PDMR Shareholding
6th Dec 20167:00 amRNSInterim Results
2nd Dec 20169:25 amRNSHolding(s) in Company
1st Dec 20169:43 amRNSTotal Voting Rights
25th Nov 20167:00 amRNSCFO Appointment
8th Nov 20161:24 pmRNSDirector/PDMR Shareholding
1st Nov 201610:15 amRNSTotal Voting Rights
31st Oct 20163:32 pmRNSDirector/PDMR Shareholding
31st Oct 20161:00 pmRNSNotice of Results
27th Oct 20167:00 amRNSCIMZIA® AutoClicks® prefilled pen launched in UK
14th Oct 201610:02 amRNSBlock listing Interim Review
14th Oct 20167:00 amRNSAnnouncement of master development agreement
11th Oct 201612:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20169:00 amRNSTotal Voting Rights
19th Sep 20169:47 amRNSBespak Technology in UCB PrefilledPen EMA Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.